Good news! Shenzhen company was awarded the Excellence award in the final Team Group of Biomedicine Group of the 11th China Shenzhen Innovation and Entrepreneurship Competition

On September 12, the 11th China Shenzhen Innovation and Entrepreneurship Competition finals

The grand award ceremony was held in Shenzhen Software Park, Nanshan District, Shenzhen

The 11th China Shenzhen Innovation and Entrepreneurship Competition (hereinafter referred to as "Shenzhen Innovation Competition") award ceremony was held in the Shenzhen branch building of China Investment Bank on September 12. Li Zhuowen, Deputy Secretary General of the Municipal Government, Huang Zhen, Deputy director of the Municipal Science and Technology Innovation Commission, Yan Tianyu, Deputy director of the Torch Center Fund Acceptance Office of the Ministry of Science and Technology, Li Jing, deputy editor-in-chief of Shenzhen Radio, Film and Television Group, attended the award ceremony and presented awards. Many relevant units and the talents of the competitors gathered together to celebrate the great event.

Since July this year, Shenzhen's biological team has gone through a series of preliminary and semifinal competitions, stood out from the 2537 project, entered the final, and won the final excellence award of the biomedical group, ranking in the top five in the competition.

Shenzhen Innovation Competition is jointly sponsored by the Shenzhen Municipal People's Government, the Torch High-tech Industry Development Center of the Ministry of Science and Technology and the Shenzhen Science and Technology Innovation Commission (Shenzhen High-tech Industrial Park Management Committee). The purpose of the competition is to advocate the culture of innovation and entrepreneurship, improve the environment for scientific and technological innovation and entrepreneurship, give full play to the guiding efficiency of government financial funds for science and technology, improve the allocation efficiency of market resources, realize the organic combination of scientific and technological innovation chain and financial capital chain, and enhance the scientific and technological innovation ability of small and medium-sized enterprises in science and technology. The Shenzhen Innovation Competition will play an important role in promoting the construction of Shenzhen's socialist pilot demonstration zone with Chinese characteristics, cultivate a group of scientific and technological rookies, and contribute to the economic and social development of Shenzhen.

   Yan Tianyu, deputy director of the Fund Acceptance Department of the Torch Center of the Ministry of Technology, said at the award ceremony that the China Innovation and Entrepreneurship Competition has been held for eight consecutive years, and more than 180,000 enterprises have participated in the competition in the past eight years, and the main body of the competition has shown a diversified trend, covering all parts of the country. Shenzhen Innovation Competition is one of the important measures to implement the CPC Central Committee and The State Council on promoting mass entrepreneurship and innovation. This year, Shenzhen selected a total of 2537 projects for the eighth China Innovation and Entrepreneurship Competition, ranking third in the country, and the number of growing enterprises is ranked second in all the competition areas.

The 11th Shenzhen Innovation and Entrepreneurship Competition qualified for the final list of biomedical group

Award certificate

A precision medicine in vitro diagnostic platform, it serves customers in a number of countries around the world and aims to establish a global R&D, marketing, and service network. At present, the research and development direction covers innovative in vitro diagnosis of pathology, innovative in vitro diagnosis of immunology and other fields. Through cutting-edge technology innovation, we provide medical device products and services for the global market, provide more perfect product solutions, and help the world improve medical conditions and improve diagnosis and treatment efficiency. The company continues to leverage its strengths in Shenzhen, a pioneering city, and is committed to innovating products and services of significant value to life and health, at a time when it is an outstanding professional healthcare solution provider in China with global influence.